Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 8 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
MS MED from Dalhem, company number BE0782347263, closed financial year 2025 with a result of € -25,010 after tax. For that financial year MS MED recorded a gross margin of € -20,963 and equity of € -5,130. Compared with financial year 2024, the result moved from € 13,953 to € -25,010. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 3, 2026.
€ -5,130
▼ € 25,010 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -25,010
▼ still € 13,953 profit in 2024
Profit after tax over the fiscal year.
€ 1,786
▼ 48% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -10,130.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 466
Supplier invoices still open on the last day of the fiscal year.
€ 6,217
▲ 3% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -4,606 | € 18,078 | € 25,831 | € -20,963 | ▼ € 46,794 |
| Profit after taxes | € -8,476 | € 9,402 | € 13,953 | € -25,010 | ▼ € 38,963 |
| Equity | € -3,476 | € 5,926 | € 19,880 | € -5,130 | ▼ € 25,010 |
| Total debts | € 31,045 | € 15,491 | € 7,641 | € 21,880 | ▲ 186% |
| Cash | € 5,195 | € 4,182 | € 3,415 | € 1,786 | ▼ 48% |
| Retained profit | € -8,476 | € 926 | € 14,880 | € -10,130 | ▼ € 25,010 |
| Bank debt | € 9,132 | € 5,424 | € 1,616 | € 0 | ▼ 100% |
| Balance sheet total | € 27,569 | € 21,417 | € 27,521 | € 16,750 | ▼ 39% |
Key figures of MS MED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MS MED?
What happened at MS MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 25,010 (▼ € 38,963 vs 2024). filed late Source: NBB ↗
- New establishment in Herstal. KBO
- New establishment in Dalhem. KBO
- Start of the company according to the CBE. KBO
In short
From € 8,476 loss in 2022 to € 25,010 loss in 2025.
Paid € 7,947 in corporate taxes since 2022.
Best year ever: 2024, with € 13,953 profit.
Management
Behind MS MED is SAMUEL NAJMA.
Directors
According to the 2025 annual accounts
SAMUEL NAJMA
Director
Establishments
Establishment units
Physical locations of this company
Rue de la Gare(WAR) 5 box 5
4608 Dalhem
En Laixheau 68
4040 Herstal
Active since 18 February 2022
Rue de la Gare(WAR) 5/5
4608 Dalhem
Active since 18 February 2022
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0782.347.263
- VAT number
- BE 0782.347.263
- Registered office
- Rue de la Gare(WAR) 5 bus 5, 4608 Dalhem
- Names & denominations
- MS MED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 February 2022
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Activiteiten van medisch specialisten